Eton Pharmaceuticals (ETON) Revenue (2019 - 2025)

Eton Pharmaceuticals (ETON) has 7 years of Revenue data on file, last reported at $21.3 million in Q4 2025.

• For the quarter ending Q4 2025, Revenue rose 82.72% year-over-year to $21.3 million; the trailing twelve-month figure through Dec 2025 stood at $80.0 million (up 104.94% YoY), and the FY2025 full-year result was $80.0 million, up 104.94% from the prior year.
• Revenue declined to $21.3 million in Q4 2025, from $22.5 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $29.8 million in Q4 2023 to a low of $775000.0 in Q3 2021.
• A 5-year average of $10.8 million and a median of $8.8 million in 2022 frame the typical range for Revenue.
• Across the five-year window, Revenue jumped 203200.0% in 2021 and tumbled 81.71% in 2022, its largest moves.
• Tracing ETON's Revenue over 5 years: stood at $6.1 million in 2021, then soared by 39.47% to $8.5 million in 2022, then surged by 250.69% to $29.8 million in 2023, then tumbled by 60.92% to $11.6 million in 2024, then jumped by 82.72% to $21.3 million in 2025.
• Business Quant data shows ETON's Revenue at $21.3 million in Q4 2025, $22.5 million in Q3 2025, and $18.9 million in Q2 2025.